Connection

David Taber to Bone Neoplasms

Back to Details
This is a "connection" page, showing publications David Taber has written about Bone Neoplasms.
David Taber
Connection Strength
0.010
Bone Neoplasms
  1. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study. J Clin Oncol. 2000 Jan; 18(2):371-5.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.